Related Experiment Videos
[Plasminogen activator inhibitors from neoplastic tissues]
1Zakład Biochemii Instytutu Badania Srodowiska i Bioanalizy Akademii Medycznej w Lodzi.
Postepy Higieny I Medycyny Doswiadczalnej
|January 1, 1991
Summary
This review surveys plasminogen activator inhibitors (PAIs) in neoplastic tissues. These diverse proteins, including PAI-1 and PAI-2 types, show varied molecular weights and functions in cancer research.
Area of Science:
- Biochemistry
- Oncology
- Molecular Biology
Context:
- Neoplastic tissues exhibit diverse plasminogen activator inhibitors (PAIs).
- PAIs are heterogeneous proteins with varying molecular weights and functions.
- These inhibitors are immunologically related to those found in normal tissues.
Purpose:
- To survey recent research on plasminogen activator inhibitors in neoplastic tissues.
- To categorize and describe different types of PAIs found in cancerous environments.
- To highlight the immunological relationships between PAIs from normal and neoplastic tissues.
Summary:
- Recent studies identify various PAIs in neoplastic tissues, including PAI-1 and PAI-2 types.
- PAI-1 types identified include acid-stable and acid-labile inhibitors from rat hepatoma, human hepatoma, fibrosarcoma, and melanoma cells.
- A PAI-2 type inhibitor from human histiocytic lymphoma cells is also described.
Impact:
- Understanding PAI diversity in cancer is crucial for developing targeted therapies.
- Characterizing these inhibitors aids in elucidating their roles in tumor progression and metastasis.
- This survey provides a foundation for future research into PAI functions in oncology.